PSMA PET Imaging of Recurrent Prostate Cancer

Running, not enrolling · Phase 2

Conditions studied: Prostate Adenocarcinoma, Prostate Cancer

In brief

The purpose of this study is to see if a new diagnostic research agent named 68Ga-HBED-CC-PSMA can show prostate cancer on a PET/CT scan that cannot be seen on other standard imaging even when the PSA levels are very low.

Key facts

Study ID
NCT03204123
Run by
Memorial Sloan Kettering Cancer Center
People needed
1171
Starts
2017-06-26
Expected to finish
2027-06-01
Last updated by the study team
2026-07-10

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.